Table 2. Demographics of the Study Population.
Parameter | All | CSC (n = 72) | Non-CSC (n = 16) |
---|---|---|---|
Mean PSA, ng/mL [range] | 21.5283 [0.02–149] | 24.5603 [0.85–149] | 7.8841 [0.02–20.4] |
Tumor location, n (%) | |||
Peripheral zone | 44 (50) | 33 (46) | 11 (69) |
Transitional zone | 25 (28) | 20 (28) | 5 (31) |
Fibromuscular zone | 4 (5) | 4 (6) | 0 (0) |
Diffuse | 15 (17) | 15 (21) | 0 (0) |
CSC = clinically significant cancer (Gleason score ≥ 7), PSA = prostate-specific antigen